2021 -now Head of Clinical Development and Regulatory Affairs @
2018 -2021 Senior Medical Director, Oncology - Therapeutic Science and Strategy Unit @
2017 -2018 European Head of Early Products Medical Affairs @
2015 -2017 European Clinical Development Head @
2015 -2015 Medical Director a.i., Oncology BU, Novartis Poland and European Medical Aff. Director New Products @
2013 -2015 European Medical Affairs Director New Products @
2010 -2013 European Medical Affairs Director Rare Tumors @
now Head of Clinical Development and Regulatory Affairs @
2002 -2005 Head of Clinical Development Europe, Novuspharma @
1995 -2002 Oncology, Therapeutic Area Leader, Medical Affairs, Aventis RPR @
1992 -1995 Internal Medicine and Nephrology Project Physician, Synthelabo @
1989 -1992 Oncology, Senior Scientific Manager @
Silvia Comis Education
Università degli Studi di Pavia
MD (Medicine)
Università degli Studi di Pavia
Board Certified (Endocrinology)
Università degli Studi di Pavia
Board Certified (Pharmacology)
Silvia Comis Skills
Clinical Research
Medicine
CTMS
Clinical Trials
Oncology
Pharmaceutical Industry
GCP
Drug Development
Clinical Development
Nephrology
Biotechnology
Therapeutic Areas
Hematology
Internal Medicine
Medical Affairs
Pharmacovigilance
Silvia Comis Summary
Silvia Comis, is currently a Head of Clinical Development and Regulatory Affairs at OSE Immunotherapeutics. Silvia Comis brings experience from previous roles at IQVIA and Novartis Oncology. Silvia Comis holds a MD in Medicine @ Università degli Studi di Pavia. With a robust skill set that includes Clinical Research, Medicine, CTMS, Clinical Trials, Oncology and more. Silvia Comis has 4 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.